Neonatal abstinence syndrome

K McQueen, J Murphy-Oikonen - New England Journal of …, 2016 - Mass Medical Soc
Neonatal Abstinence Syndrome | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Neonatal abstinence syndrome: advances in diagnosis and treatment

EM Wachman, DM Schiff, M Silverstein - Jama, 2018 - jamanetwork.com
Importance Neonatal abstinence syndrome, which occurs as a result of in utero opioid
exposure, affects between 6.0 and 20 newborns per 1000 live US births. There is substantial …

[HTML][HTML] Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: literature review to support …

SL Klaman, K Isaacs, A Leopold, J Perpich… - Journal of addiction …, 2017 - journals.lww.com
Objectives: The prevalence of opioid use disorder (OUD) during pregnancy is increasing.
Practical recommendations will help providers treat pregnant women with OUD and reduce …

Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome

EM Wachman, M Grossman, DM Schiff… - Journal of …, 2018 - nature.com
Abstract Objectives To improve Neonatal Abstinence Syndrome (NAS) inpatient outcomes
through a comprehensive quality improvement (QI) program. Design Inclusion criteria were …

Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS)

AK Mangat, GM Schmölzer, WK Kraft - Seminars in Fetal and Neonatal …, 2019 - Elsevier
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants
develop after intrauterine maternal drug exposure. All infants with documented in utero …

Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial

JM Davis, J Shenberger, N Terrin, JL Breeze… - JAMA …, 2018 - jamanetwork.com
Importance Although opioids are used to treat neonatal abstinence syndrome (NAS), the
best pharmacologic treatment has not been established. Objective To compare the safety …

Wide variation found in care of opioid-exposed newborns

DL Bogen, BL Whalen, LR Kair, M Vining, BA King - Academic pediatrics, 2017 - Elsevier
Objective Standardized practices for the management of neonatal abstinence syndrome
(NAS) are associated with shorter lengths of stay, but optimal protocols are not established …

Pharmacological treatments for neonatal abstinence syndrome: a systematic review and network meta-analysis

T Disher, C Gullickson, B Singh, C Cameron… - JAMA …, 2019 - jamanetwork.com
Importance Incidence of neonatal abstinence syndrome is rising rapidly, and optimal
pharmacotherapy may meaningfully reduce length of treatment. Objective To compare …

Neurodevelopmental outcomes of neonates randomized to morphine or methadone for treatment of neonatal abstinence syndrome

AJ Czynski, JM Davis, LM Dansereau… - The Journal of …, 2020 - Elsevier
Objective To evaluate the effects of pharmacologic treatment of neonatal abstinence
syndrome on neurodevelopmental outcome from a randomized, controlled trial. Study …

Ohio perinatal quality collaborative improves care of neonatal narcotic abstinence syndrome

MC Walsh, M Crowley, S Wexelblatt, S Ford… - …, 2018 - publications.aap.org
OBJECTIVES: Neonatal abstinence syndrome (NAS) after an infant's in-utero exposure to
opioids has increased dramatically in incidence. No treatment standards exist, leading to …